Vol. 59 No. 9 (2020): Acta Oncologica

Articles

• Evaluation of the stage classification of anal cancer by the TNM 8th version versus the TNM 7th version

  Olav Dahl, Mette Pernille Myklebust, Jon Espen Dale, Otilia Leon, Eva Serup-Hansen, Anders Jakobsen, Per Pfeiffer, Inger Marie Løes, Frank Pfeffer, Karen-Lise Garm Spindler, Marianne Grønlie Guren, Bengt Glimelius, Anders Johnsson

  1016-1023

  Published: 2020-09-01

  • PDF

• Randomized phase III trial comparing switch-maintenance pemetrexed with observation followed by pemetrexed at progression in advanced NSCLC

  Tarje O. Halvorsen, Kristin Stokke, Kristin T. Killingberg, Sunil X. Raj, Sveinung Sørhaug, Odd Terje Brustugun, Øystein Fløtten, Nina Helbekkmo, Kjersti Hornslien, Tesfaye Madebo, Sverre Fluge, Bjørn Henning Grønberg

  1051-1057

  Published: 2020-09-01

  • PDF

• Impact of performance status on non-small-cell lung cancer patients with a PD-L1 tumour proportion score ≥50% treated with front-line pembrolizumab

  Alex Friedlaender, Giulio Metro, Diego Signorelli, Alessio Gili, Panagiota Economopoulou, Fausto Roila, Giuseppe Banna, Alessandro De Toma, Andrea Camerini, Athina Christopoulou, Giuseppe Lo Russo, Marco Banini, Domenico Galetta, Beatriz Jimenez, Ana Collazo-Lorduy, Antonio Calles, Panagiotis Baxevanos, Helena Linardou, Paris Kosmidis, Giannis Mountzios, Marina C. Garassino, Alfredo Addeo

  1058-1063

  Published: 2020-09-01

  • PDF

• Metastasis directed treatment of brain metastases from colorectal cancer – a Danish population-based cohort study

  A. K. Boysen, A. G. Ording, A. Astradsson, M. Høyer, K.-L. Spindler

  1118-1122

  Published: 2020-09-01

  • PDF

• Drug repositioning in cancer: a role for antihistamines in breast cancer?

  Mef Nilbert, Lene Mellemkjær

  1007-1008

  Published: 2020-09-01

  • PDF

• Early progression of breast cancer during neoadjuvant chemotherapy may predict poorer prognoses

  Sylvia Myller, Pieta Ipatti, Anniina Jääskeläinen, Arja Jukkola, Peeter Karihtala

  1036-1042

  Published: 2020-09-01

  • PDF

• National e-library for standardized chemotherapy regimens

  AnnSofie Fyhr, Jonas Borell, Mats Jerkeman, Åsa Ek

  1079-1083

  Published: 2020-09-01

  • PDF

• Desloratadine and loratadine stand out among common H1-antihistamines for association with improved breast cancer survival

  Ildikó Fritz, Philippe Wagner, Per Broberg, Rickard Einefors, Håkan Olsson

  1103-1109

  Published: 2020-09-01

  • PDF

• Molecular genetic changes in solid pseudopapillary neoplasms (SPN) of the pancreas

  Elisa Rodriguez-Matta, Amanda Hemmerich, Jason Starr, Kabir Mody, Eric A. Severson, Gerardo Colon-Otero

  1024-1027

  Published: 2020-09-01

  • PDF

• Randomised comparison of 1.1 GBq and 3.7 GBq radioiodine to ablate the thyroid in the treatment of low-risk thyroid cancer: a 13-year follow-up

  Veera Ahtiainen, Leila Vaalavirta, Mikko Tenhunen, Heikki Joensuu, Hanna Mäenpää

  1064-1071

  Published: 2020-09-01

  • PDF

• Longitudinal study of cognitive function in glioma patients treated with modern radiotherapy techniques and standard chemotherapy

  Anna Rydelius, Jimmy Lätt, Sara Kinhult, Silke Engelholm, Danielle Van Westen, Mats Pihlsgård, Johan Bengzon, Pia C. Sundgren, Åsa Lilja

  1091-1097

  Published: 2020-09-01

  • PDF

• An economic evaluation of eribulin for advanced breast cancer treatment based on the Southeast Netherlands advanced breast cancer registry

  Xavier G. L. V. Pouwels, Bram L. T. Ramaekers, Sandra M. E. Geurts, Frans Erdkamp, Birgit E. P. J. Vriens, Kirsten N. A. Aaldering, Agnes J. van de Wouw, M. W. Dercksen, Tineke J. Smilde, Natascha A. J. B. Peters, J. M. G. H. van Riel, Manon J. Pepels, Jose `Heijnen-Mommers, Vivianne C. G. Tjan-Heijnen, Maaike de Boer, Manuela A. Joore

  1123-1130 |

  Published: 2020-09-01

  • PDF

• Predictive pharmacogenetic biomarkers for breast cancer recurrence prevention by simvastatin

  Thomas P. Ahern, Per Damkier, Søren Feddersen, Anders Kjærsgaard, Timothy L. Lash, Stephen Hamilton-Dutoit, Cathrine Bredal Lythjohan, Bent Ejlertsen, Peer M. Christiansen, Deirdre P. Cronin-Fenton

  1009-1015 |

  Published: 2020-09-01

  • PDF

• Oncological management of pregnancy-associated cancers: analysis from the French CALG (Cancer Associé à La Grossesse) network

  Anne-Sophie Boudy, François Zaccarini, Lise Selleret, Alexandra Arfi, Ilaria Guiggi, Cyril Touboul, Sofiane Bendifallah, Emile Darai

  1043-1050

  Published: 2020-09-01

  • PDF

• Maintenance therapy and drug holiday in sarcoma patients: systematic review

  Loïc Lebellec, Anne-Sophie Defachelles, Pierre-Yves Cren, Nicolas Penel

  1084-1090 |

  Published: 2020-09-01

  • PDF

• Survival after breast cancer in women with type 2 diabetes using antidiabetic medication and statins: a retrospective cohort study

  Mayu Hosio, Elina Urpilainen, Ari Hautakoski, Mikko Marttila, Martti Arffman, Reijo Sund, Anne Ahtikoski, Ulla Puistola, Peeter Karihtala, Arja Jukkola, Esa Läärä

  1110-1117

  Published: 2020-09-01

  • PDF

• The value of sorafenib trough levels in patients with advanced hepatocellular carcinoma – a substudy of the SORAMIC trial

  Tim A. Labeur, Quincy Hofsink, R. Bart Takkenberg, Otto M. van Delden, Ron A. A. Mathôt, Regina Schinner, Peter Malfertheiner, Holger Amthauer, Kerstin Schütte, Bristi Basu, Christiane Kuhl, Julia Mayerle, Jens Ricke, Heinz-Josef Klümpen

  1028-1035

  Published: 2020-09-01

  • PDF

• Association between variations in the number of hospital beds and inpatient chemo/radiotherapy for breast cancer: a study using a large claim database

  Haruki Harry Matsumoto, Rin Ogiya, Shinya Matsuda

  1072-1078

  Published: 2020-09-01

  • PDF

• Interindividual changes in peak oxygen consumption in patients with colorectal cancer following endurance training: a secondary analysis of the I-WALK-CRC study

  Simon Nørskov Thomsen, Anna Sundberg, Jens Osterkamp, Sarah Thorsen-Streit, Kell Østerlind, Peter- Martin Krarup, Kirsten Vistisen, Bente Klarlund Pedersen, Jesper Frank Christensen

  1098-1102

  Published: 2020-09-01

  • PDF

• Rate of locoregional recurrence among patients with oropharyngeal squamous cell carcinoma with known HPV status: a systematic review

  Jasmin Asheer, Jakob Schmidt Jensen, Christian Grønhøj, Kathrine K. Jakobsen, Christian von Buchwald

  1131-1136

  Published: 2020-09-01

  • PDF